Cactus Life Sciences completes acquisition of nspm and eluSCIdate to expand rare disease expertise and global event proficiency
Acquiring Company
Cactus Life Sciences
Acquired Company
nspm
Princeton
MeggenMeggenBiotechnologyHealth CarePharmaceuticalHealth CareMedicalDescription
Cactus Life Sciences, a leading global scientific communications agency, has announced the acquisition of nspm and eluSCIdate, two dynamic medical communications and publications companies. This acquisition is part of Cactus Life Sciences' exciting buy-and-build strategy to expand its services, especially in rare disease expertise and global event proficiency, as it seeks partnerships that prioritize its people and clients alongside its strategic growth.
Quick answer
Cactus Life Sciences is acquiring nspm and eluSCIdate, announced April 24, 2024. Cactus Life Sciences is based in Princeton, New Jersey, United States.
- How much did Cactus Life Sciences pay for nspm?
- The deal value was not disclosed.
- What does Cactus Life Sciences do?
- Cactus Life Sciences redefines efficiency.
- Where are Cactus Life Sciences and nspm based?
- Cactus Life Sciences is based in Princeton, New Jersey, United States. nspm is based in Meggen, Lucerne, Switzerland.
Source: Fundz verified event record.
Other recent acquisitions in Pharmaceutical and Medical
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Cycle Pharmaceuticals proposes to acquire Vanda Pharmaceuticals for $8.00 per share (June 6, 2024)
- Eli Lilly and Company acquires manufacturing facility from Nexus Pharmaceuticals to expand U.S. capacity (April 22, 2024)
- Juvisé Pharmaceuticals acquires rights to MS therapy Ponvory outside North America (April 2, 2024)
- AbbVie finalizes acquisition of Landos Biopharma, Inc. to advance treatment for ulcerative colitis and Crohn's disease (May 23, 2024)
- LCI completes acquisition of certain assets of Pfizer Pakistan Limited and Pfizer Inc. to enhance pharmaceutical portfolio (May 20, 2024)
- Future Pak proposes acquisition of Vanda Pharmaceuticals for $7.25 to $7.75 per share in cash (April 17, 2024)
Who to call at Cactus Life Sciences, and when
When Cactus Life Sciences changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Cactus Life Sciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Cactus Life Sciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Cactus Life Sciences. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Cactus Life Sciences makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired nspm?
nspm was acquired by Cactus Life Sciences, based in Princeton. The deal was reported on April 24, 2024. Cactus Life Sciences redefines efficiency. We provide scientific content across the healthcare continuum, anywhere in the world – with a focus on science, innovation, and efficiency. Our approach is simple yet powerful. Cactus Life Sciences is privately held and operates in Biotechnology.
When did Cactus Life Sciences acquire nspm?
Cactus Life Sciences's acquisition of nspm was reported on April 24, 2024. Cactus Life Sciences, a leading global scientific communications agency, has announced the acquisition of nspm and eluSCIdate, two dynamic medical communications and publications companies. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does nspm do?
nspm is a successful and dynamic medical communications company founded in 1997 with offices in Switzerland and the UK. It is privately held, operating in Health Care, and is based in Meggen.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.